Drug Design

Arli Aditya Parikesit

ISBN 10: 1789847524 / ISBN 13: 9781789847529

Published by Intechopen Jun 2021, 2021

About this Item

This item is printed on demand - it takes 3-4 days longer - Neuware -Right before the COVID-19 pandemic declared by the World Health Organization (WHO), life sciences have incited novel areas of studies that revolutionize the health sector. They are the studies of structural bioinformatics, pharmacogenomics, and metabolomics. The structural bioinformatics field is the very foundation of drug design research, as it provides insight into the molecular simulations and interactions between the biomolecules and the drug candidates. Secondly, pharmacogenomics is the starting point of any efforts in developing personalized medicine. Lastly, metabolomics provides instrumentation to elicit biomarkers for various diseases and health conditions. These studies have enabled current accelerated effort in COVID-19 research, as well as other communicable and non-communicable diseases. 158 pp. Englisch.

Seller Inventory # 9781789847529

Bibliographic Details

• Title: Drug Design
• Publisher: Intechopen Jun 2021
• Publication Date: 2021
• Language: English
• ISBN 10: 1789847524
• ISBN 13: 9781789847529
• Binding: Buch
• Condition: Neu
• Dimensions: 266W x 185H x 16D millimeters 266 millimeters width by 185 millimeters height by 16 millimeters depth
• Weight: 562 grams

About this title

Synopsis

Right before the COVID-19 pandemic declared by the World Health Organization (WHO), life sciences have incited novel areas of studies that revolutionize the health sector. They are the studies of structural bioinformatics, pharmacogenomics, and metabolomics. The structural bioinformatics field is the very foundation of drug design research, as it provides insight into the molecular simulations and interactions between the biomolecules and the drug candidates. Secondly, pharmacogenomics is the starting point of any efforts in developing personalized medicine. Lastly, metabolomics provides instrumentation to elicit biomarkers for various diseases and health conditions. These studies have enabled current accelerated effort in COVID-19 research, as well as other communicable and non-communicable diseases.